欢迎来到天天文库
浏览记录
ID:54923567
大小:722.41 KB
页数:5页
时间:2020-05-04
《TACE联合PMCT序贯自身肿瘤疫苗与免疫效应细胞治疗大肝癌临床观察-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库。
1、徐永茂,等TACE联合PMCT序贯自身月瘤疫苗免瘗墼堕月干堕!堕塑窒临床应用研究/论著TACE联合PMCT序贯自身肿瘤疫苗与免疫效应细胞治疗大肝癌临床观察徐永茂徐冬云张南征史跃栾智勇刘军权徐州解放军第九七医院(肿瘤科:徐永茂,徐冬云,张南征;介入科:史跃,栾智勇;实验科:刘军权),江苏徐州221004【摘要】目的:评价经皮肝动脉化疗栓塞(transcatheterarterial,TACE)联合经皮冷循环微波凝固(percataneousmicro—wavecoaqulationtherapy,PMCT)序贯人自体肝癌细胞
2、溶胞产物荷栽树突状细胞(dendriticceils,DC)和细胞因子诱导杀伤(cytokine—inducedkiller,CIK)细胞、yST细胞治疗原发性大肝癌的临床疗效。方法:收集2008—01—01—2011-12—31徐州解放军第九七医院80例不能切除的原发性大肝癌患者随机分为研究组(过继性细胞免疫治疗)和对照组(TACE+PMCT),每组各4O例。对照组患者先行TACE,5~7d复查增强CT和彩超了解肿瘤碘油沉积和血供后再行PMCT;研究组TACE+PMCT方法同对照组,PMCT后行免疫效应细胞(肝癌细胞溶胞
3、产物荷载DC+CIK细胞+y6T细胞)治疗,采用静脉回输+肝瘤体内注射。随访6~36个月,观察治疗前后肿瘤影像学资料(增强CT、彩超)、肝功能、AFP、免疫功能、生活质量、生存及并发症。结果:研究组和对照纽有效率分别为9O和85,差畀无统计学意义,x。一0.457,P=0.737。研究组治疗后的CD4。。、CD4/CD8和NK细胞均明显高于治疗前、也明显高于对照组的治疗后,差异有统计学意义,P<0.05。两组治疗后CD4CD25FOXP+3/CD4均明显低于治疗前,差异有统计学意义,P<0.05。研究组和对照组治疗后AFP
4、下降>8O的分别为77.8和67.5,差异无统计学意义,Y一2.125,P一0.145。研究组的生存质量明显高于对照组,差异有统计学意义,P5、。【关键词】癌,肝细胞;化学栓塞;微波;过继性细胞免疫治疗中华肿瘤防治杂志,2013,20(24):l928—1932TACEcombinedPMCTsequentialowncancervaccineandimmunoeffeetorcellstotreatlargehepatOcellularcarcinomaclinicalobservationxuYong一7nao,XUDong—yun,ZHANGNan—zheng,SHIYue,LUANZhi—yong,L儿_,Jun—quanDepartmentofOncol6、ogythe97thHospitalPLA,Xuzhou221004,P.R.China[ABSTRACT]OBJECTIVE:Toevaluatetheclinicalvalueoftranscatheterarterialchemoembolization(TACE)combinedwithultrasonicguidedwatercirculatorycoolingpercutaneousmicrowavecoagulationtherapy(PMCT)andsequentialwithdendriticcells(7、DC)pulsedwithautologoushepatomaceillysatesandCytokine-inducedkiller(CIK)ceilsandy3Tceilsintreatmentoflargehepatocellularcarcinoma(HCC).METHODS:From2008—01—01to2011~12—31,departmentofoncologythe97thHospitalofPLA,80patientswithunresectablelargeHCCwererandomizedintos8、tudygroup(TACE+PMCT+DCpulsedwithautologoushepatomacell1ysatesandCIKcellsandY8Tcells,z一40)andcontrolgroup(TACE+PMCT,2=40).Patientsofcontrolgroupweretreat
5、。【关键词】癌,肝细胞;化学栓塞;微波;过继性细胞免疫治疗中华肿瘤防治杂志,2013,20(24):l928—1932TACEcombinedPMCTsequentialowncancervaccineandimmunoeffeetorcellstotreatlargehepatOcellularcarcinomaclinicalobservationxuYong一7nao,XUDong—yun,ZHANGNan—zheng,SHIYue,LUANZhi—yong,L儿_,Jun—quanDepartmentofOncol
6、ogythe97thHospitalPLA,Xuzhou221004,P.R.China[ABSTRACT]OBJECTIVE:Toevaluatetheclinicalvalueoftranscatheterarterialchemoembolization(TACE)combinedwithultrasonicguidedwatercirculatorycoolingpercutaneousmicrowavecoagulationtherapy(PMCT)andsequentialwithdendriticcells(
7、DC)pulsedwithautologoushepatomaceillysatesandCytokine-inducedkiller(CIK)ceilsandy3Tceilsintreatmentoflargehepatocellularcarcinoma(HCC).METHODS:From2008—01—01to2011~12—31,departmentofoncologythe97thHospitalofPLA,80patientswithunresectablelargeHCCwererandomizedintos
8、tudygroup(TACE+PMCT+DCpulsedwithautologoushepatomacell1ysatesandCIKcellsandY8Tcells,z一40)andcontrolgroup(TACE+PMCT,2=40).Patientsofcontrolgroupweretreat
此文档下载收益归作者所有